N

Nadia Harbeck

ORCID: 0000-0002-9744-7372

Publishes on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research. 2.1k papers and 87.4k citations.

PubIndex Score98Top 2%How it's scored

2.1kPublications

87.4kTotal Citations

First publication: 1987First senior author: 2001

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Estrogen and related hormone effects

Top publicationsby citations

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid, Joyce O’Shaughnessy, Javier Cortés et al.|New England Journal of Medicine|2020

Cited by 3.1k

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn, Dennis J. Slamon, Miguel Martín et al.|New England Journal of Medicine|2016

Cited by 2.9k

Nadia Harbeck, Fátima Cardoso, Frédérique Penault‐Llorca et al.|Nature Reviews Disease Primers|2019

Cited by 2.9k

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, David Cameron, William Jacot et al.|New England Journal of Medicine|2022

Cited by 2.5k

Nadia Harbeck, Michael Gnant|The Lancet|2016

Cited by 2.3k